Clarassance

About:

Clarassance is a clinical-stage biotechnology company developing secretoglobin-based biopharmaceutical products.

Website: http://clarassance.com

Description:

Clarassance is a privately-held, clinical-stage Delaware Corporation headquartered in Rockville, Maryland. Our mission is to develop biopharmaceutical products based on the unique family of proteins called secretoglobins. There are several secretoglobins made in the human body, the most abundant of which is called CC10. CC10 is a potent anti-inflammatory agent that may bring benefit in many types of disease.

Total Funding Amount:

$7.75M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2007-01-01

Contact Email:

aprile.pilon(AT)clarassance.com

Founders:

Aprile Pilon

Number of Employees:

11-50

Last Funding Date:

2014-06-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai